Search Results
Can Venetoclax plus Azacitidine Help AML Patients Ineligible for Intensive Treatment?
Venetoclax and azacitidine for AML ineligible for standard induction
Treatment strategies for patients with IDH1/2-mutated AML ineligible for intensive chemotherapy
allo-SCT improves survival following venetoclax and azacitidine therapy in AML
Venetoclax plus azacitidine in FLT3-mutated AML
Results of venetoclax and azacitidine combination in chemotherapy ineligible untreated patients ...
IMGN632 plus venetoclax and/or azacitidine for patients with CD123-positive AML
Venetoclax + azacitidine in unfit patients with AML
Pevonedistat, venetoclax and azacitidine for older AML patients
Rationale of OMNIVERSE: oral azacitidine + venetoclax in patients with R/R or newly diagnosed AML
AML: Managing AEs With Venetoclax + Azacitidine
Phase II study of venetoclax and azacitidine vs induction chemotherapy in fit patients with AML
